Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,015.40
-31.60 (-1.54%)
Dec 24, 2025, 3:29 PM IST
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 15,800 employees as of March 31, 2025. The number of employees increased by 811 or 5.41% compared to the previous year.
Employees
15,800
Change (1Y)
811
Growth (1Y)
5.41%
Revenue / Employee
10.12M INR
Profits / Employee
639.14K INR
Market Cap
570.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15,800 | 811 | 5.41% |
| Mar 31, 2024 | 14,989 | -567 | -3.64% |
| Mar 31, 2023 | 15,556 | 141 | 0.91% |
| Mar 31, 2022 | 15,415 | 4,451 | 40.60% |
| Mar 31, 2021 | 10,964 | 297 | 2.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Biocon | 16,315 |
Glenmark Pharmaceuticals News
- 2 days ago - Glenmark Pharma launches Epinephrine Injection USP multiple-dose vial in the US - Business Upturn
- 8 days ago - Top stocks to watch today, December 17: Ola Electric, NBCC, Ahluwalia Contracts, Glenmark Pharma, BEML and more - Business Upturn
- 8 days ago - Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib - Business Upturn
- 14 days ago - Glenmark Pharma to launch Leucovorin Calcium for Injection USP, 350 mg/vial in the U.S. market - Business Upturn
- 24 days ago - Glenmark’s Aurangabad Facility Clears US FDA Inspection With Zero Observations - Business Upturn
- 4 weeks ago - Glenmark Pharma receives US FDA EIR with VAI status for Monroe facility - Business Upturn
- 4 weeks ago - Glenmark Pharma launches world’s first bebulized triple therapy for COPD in India - Business Upturn
- 5 weeks ago - HSBC cuts Glenmark’s target price to Rs 2,110, says abnormal quarter driven by upfront ISB payment and India disruption - Business Upturn